» Articles » PMID: 35628481

The Involvement of Alarmins in the Pathogenesis of Sjögren's Syndrome

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 May 28
PMID 35628481
Authors
Affiliations
Soon will be listed here.
Abstract

Sjögren's syndrome (SS) is a chronic autoimmune disease that affects exocrine glands, primarily the salivary and lachrymal glands. It is characterized by lymphoplasmacytic infiltration of the glandular tissues, ultimately leading to their dysfunction and destruction. Besides classic dry eyes and dry mouth defined as sicca syndrome, patients affected by the disease also typically display symptoms such as fatigue, pain and in more than 50% of cases, systemic manifestations such as arthritis, interstitial lung involvement, neurological involvement and an increased risk of lymphoma. The pathophysiological mechanisms underlying SS still remain elusive. The crucial role of innate immunity has been advocated in recent years regarding the pathogenesis of pSS, especially in the initiation and progression toward autoimmunity. Alarmins are endogenous molecules that belong to the large family of damage associated molecular pattern (DAMP). Alarmins are rapidly released, ensuing cell injury and interacting with pattern recognition receptors (PRR) such as toll-like receptors (TLR) to recruit and activate cells of the innate immune system and to promote adaptive immunity responses. This review highlights the current knowledge of various alarmins and their role in the pathogenesis of pSS.

Citing Articles

The role of cytokines from salivary gland epithelial cells in the immunopathology of Sjögren's syndrome.

Dong Y, Wang T, Wu H Front Immunol. 2024; 15:1443455.

PMID: 39346911 PMC: 11427401. DOI: 10.3389/fimmu.2024.1443455.


Decreased expression of TIGIT on CD14 + monocytes correlates with clinical features and laboratory parameters of patients with primary Sjögren's syndrome.

Zhao P, Peng C, Chang X, Cheng W, Yang Y, Shen Y Clin Rheumatol. 2023; 43(1):297-306.

PMID: 37749409 DOI: 10.1007/s10067-023-06759-6.


Marginal Zone B (MZB) Cells: Comparison of the Initial Identification of Immune Activity Leading to Dacryoadenitis and Sialadenitis in Experimental Sjögren's Syndrome.

Peck A, Ambrus Jr J Int J Mol Sci. 2023; 24(15).

PMID: 37569583 PMC: 10419086. DOI: 10.3390/ijms241512209.


Aquaporin-5 Dynamic Regulation.

DAgostino C, Parisis D, Chivasso C, Hajiabbas M, Soyfoo M, Delporte C Int J Mol Sci. 2023; 24(3).

PMID: 36768212 PMC: 9915196. DOI: 10.3390/ijms24031889.


A Temporal Comparative RNA Transcriptome Profile of the Annexin Gene Family in the Salivary versus Lacrimal Glands of the Sjögren's Syndrome-Susceptible C57BL/6.NOD- Mouse.

Peck A, Ambrus Jr J Int J Mol Sci. 2022; 23(19).

PMID: 36233010 PMC: 9570365. DOI: 10.3390/ijms231911709.


References
1.
Michalak M, Parker J, Opas M . Ca2+ signaling and calcium binding chaperones of the endoplasmic reticulum. Cell Calcium. 2003; 32(5-6):269-78. DOI: 10.1016/s0143416002001884. View

2.
Li B, Sheng M, Li J, Yan G, Lin A, Li M . Tear proteomic analysis of Sjögren syndrome patients with dry eye syndrome by two-dimensional-nano-liquid chromatography coupled with tandem mass spectrometry. Sci Rep. 2014; 4:5772. PMC: 4145314. DOI: 10.1038/srep05772. View

3.
Kiripolsky J, Romano R, Kasperek E, Yu G, Kramer J . Activation of Myd88-Dependent TLRs Mediates Local and Systemic Inflammation in a Mouse Model of Primary Sjögren's Syndrome. Front Immunol. 2020; 10:2963. PMC: 6964703. DOI: 10.3389/fimmu.2019.02963. View

4.
Cavalli G, Colafrancesco S, Emmi G, Imazio M, Lopalco G, Maggio M . Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and treatment of autoimmune and inflammatory diseases. Autoimmun Rev. 2021; 20(3):102763. DOI: 10.1016/j.autrev.2021.102763. View

5.
Kageyama G, Saegusa J, Irino Y, Tanaka S, Tsuda K, Takahashi S . Metabolomics analysis of saliva from patients with primary Sjögren's syndrome. Clin Exp Immunol. 2015; 182(2):149-53. PMC: 4608504. DOI: 10.1111/cei.12683. View